| Application no. and date | 01952412.3 (espacenet) (Federated) (European Patent Register), 20010703 | | Patent/reg. no. and date | DK/EP 1296645, 20060913 | | Publication date | 20030402 | | Priority no. and date | US 216236 P, 20000705, US 693008, 20001020 | | EP pub. no. and date |
EP 1296645 20030402 | | Effective date | | | Applicant/owner | Allergan Inc., 2525 Dupont Drive
Irvine, CA 92612, US | | Applicant ref. no. | P80601507DK00E | | Inventor | WONG, Vernon, G., 180 Sand Hill Circle
Menlo Park, CA 94025, US,
HU, Mae, W., L., 26705 St. Francis Drive
Los Altos Hills, CA 94022, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/56 (2006.01) , A61K 31/57 (2006.01) , A61K 47/34 (2006.01) , A61K 9/00 (2006.01) | | Title | Fremgangsmåder til behandling af inflammationsmedierede tilstande i øjet | | Int. application no. | US2001021173 | | Int. publication no. | WO2002002076 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
